Results 21 to 30 of about 322,632 (326)

JAK3 as an emerging target for topical treatment of inflammatory skin diseases [PDF]

open access: yes, 2016
The recent interest and elucidation of the JAK/STAT signaling pathway created new targets for the treatment of inflammatory skin diseases (ISDs). JAK inhibitors in oral and topical formulations have shown beneficial results in psoriasis and alopecia ...
Alves de Medeiros, Ana   +5 more
core   +8 more sources

The role of 39 psoriasis risk variants on age of psoriasis onset. [PDF]

open access: yes, 2013
Recent genome-wide association studies (GWAS) have identified multiple genetic risk factors for psoriasis, but data on their association with age of onset have been marginally explored.
Butler, Daniel   +12 more
core   +2 more sources

Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome CoronavirusĀ 2 (SARS-CoV-2)

open access: yesDermatology and Therapy, 2020
The outbreak of the novel coronavirus known as SARS-CoV-2 (severe acute respiratory syndrome coronavirusĀ 2) causing COVID-19 was first reported in late December 2019.
Nicholas D. Brownstone   +6 more
doaj   +1 more source

Multi-omics integration reveals molecular networks and regulators of psoriasis. [PDF]

open access: yes, 2019
BackgroundPsoriasis is a complex multi-factorial disease, involving both genetic susceptibilities and environmental triggers. Genome-wide association studies (GWAS) and epigenome-wide association studies (EWAS) have been carried out to identify genetic ...
Arneson, Douglas   +5 more
core   +3 more sources

Oral warty dyskeratoma: An unusual presentation

open access: yesDermatology Reports, 2020
Warty dyskeratoma is an uncommon benign skin lesion, which is mostly limited to the head or neck and is rarely seen in other areas of the skin or mucous membranes.
Hamid Reza Ghasemi Basir   +3 more
doaj   +1 more source

Evaluation of the cutaneous microbiome in psoriasis [PDF]

open access: yes, 2010
Psoriasis, a highly prevalent disease of humans of unknown cause, is a chronic inflammatory disorder primarily involving skin, with distinctive clinical characteristics.
Alexander Alekseyenko   +5 more
core   +2 more sources

The Correlation between the Vascular Calcification Score of the Coronary Artery and the Abdominal Aorta in Patients with Psoriasis

open access: yesDiagnostics, 2023
Psoriasis is known as an independent risk factor for cardiovascular disease due to its chronic inflammation. Studies have been conducted to evaluate the progress of atherosclerotic plaques in psoriasis.
Trang Nguyen-Mai Huynh   +7 more
doaj   +1 more source

Plasma total antioxidant capacity and peroxidation biomarkers in psoriasis [PDF]

open access: yes, 2016
Systemic biomarkers of oxidative stress can be relevant for assessment of psoriasis severity, for prediction of the outcome of therapy and of the development of comorbidities.
Cavaliere, Arturo   +2 more
core   +2 more sources

Treatment of Psoriasis Vulgaris with Calcipotriol Betamethasone Dipropionate Combination Followed by Calcipotriol and Assessment of the Adjuvant Basic Use of Urea-Based Emollients

open access: yesEuropean Journal of Inflammation, 2005
A new combination product containing betamethasone dipropionate and calcipotriol (DovobetĀ® ointment) has been proven very effective and well tolerated in patients with psoriasis vulgaris.
G.A. Vena   +37 more
doaj   +1 more source

Viewpoint on handling anti-TNF failure in psoriasis [PDF]

open access: yes, 2013
An association among the occurrence of antidrug antibodies (ADAs), diminished trough serum drug levels (TSDLs) and non-response or loss of response has been described for several tumor necrosis factor alpha (TNF) blocking agents in a variety of diseases,
BRACKE, STEFANIE, Lambert, Jo
core   +1 more source

Home - About - Disclaimer - Privacy